Clinical Study

A Prospective Phase II Trial Of Novottf-100A With Bevacizumab (Avastin) In Patients With Recurrent Glioblastoma

Posted Date: Apr 5, 2017

  • Investigator: Rekha Chaudhary
  • Co-Investigator: Alison Kastl
  • Specialties: Hematology/Oncology, Oncology, Neurosurgery, Cancer, Neurology
  • Type of Study: Drug

The purpose of this study is to determine the efficacy of the combination of Bevacizumab and NovoTTF-100A in Bevacizumab naïve (meaning you have never received bevacizumab before) patients with recurrent GBM as measured by 6-month progression free surviva

Criteria:

To Be Eligible For This Study, Patients Must Have Been Diagnosed With A Brain Tumor Called Glioblastoma Or Other Grade Iv Malignant Glioma (I.E. Gliosarcoma, Small Cell Glioblastoma, Etc).

Keywords:

Cancer, Glioma, Brain Tumor, Cae3313, Brain

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.